Zhansheng Weige Chaoyue Xilishi recalls
The FDA has published 1 recall involving Zhansheng Weige Chaoyue Xilishi since 2018. The latest was reported on 7 Feb 2018. Most were for hidden drug ingredients. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2018
Last 12 months0reported
Class I1100% of total
Ongoing0latest 7 Feb 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why zhansheng weige chaoyue xilishi is recalled
Companies
By year
All zhansheng weige chaoyue xilishi recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Zhansheng Weige Chaoyue Xilishi tablets, 2000 mg recalled by A&H Focal | A&H Focal | Hidden Drug Ingredients | NJ, NY |
Should you stop taking Zhansheng Weige Chaoyue Xilishi?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.